How to enforce your patent portfolio

Many biotechnology companies are looking hard at their patent portfolios to raise extra revenues. Orrick, Herrington & Sutcliffe's Craig Kaufman and Anne-Marie Dinius reveal how biotech companies can use the law to enhance their ability to enforce their patent rights